Drawing for MAVENCLAD

USPTO serial 79202778

MAVENCLAD

Reviewed by CopyMark Law Group

Reg. 5253420Status 739Renewal
Filing date
Status date
Registration date
Aug 1, 2017
Examiner
LAM, HAI-LY HUYNH
Law office
GENERIC WEB UPDATE

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Need help with MAVENCLAD?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*

Plus Government fees of $650

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

William C. Wright

William C. Wright Epstein Drangel LLP60 East 42nd Street, Suite 1250New York, NY 10165UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical products, namely, pharmaceutical preparations for the treatment of inflammatory and immunological diseases and disordersACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 1, 2026REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
Mar 26, 2024NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED—
Mar 26, 2024C75AREGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.—
Mar 25, 2024APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jul 13, 2023ES75TEAS SECTION 71 & 15 RECEIVED—
Aug 1, 2022REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Dec 8, 2017FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Nov 21, 2017FICSFINAL DISPOSITION NOTICE SENT TO IB—
Nov 21, 2017FIMPFINAL DISPOSITION PROCESSED—
Nov 1, 2017FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Aug 1, 2017R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 16, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 16, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 26, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 15, 2017RFNTREFUSAL PROCESSED BY IB—
Apr 4, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 3, 2017TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 3, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 3, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 3, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 30, 2017RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 30, 2017RFRRREFUSAL PROCESSED BY MPU—
Mar 29, 2017RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 28, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 24, 2017DOCKASSIGNED TO EXAMINER—
Mar 14, 2017MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 10, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 9, 2017REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance